Results 121 to 130 of about 773 (166)
Nivolumab-Induced Fasciitis Mimicking Scleroderma: A Diagnostic Challenge. [PDF]
CureusJannat R, Kshatri M, Thapa R.
europepmc +1 more source
Histopathologic characteristics of scleromyxedema: A study of a series of 34 cases
Journal of the American Academy of Dermatology, 2016 Background Few histologic studies describe the histopathologic aspects of scleromyxedema. Objective We sought to describe the histopathologic and immunohistochemical features of scleromyxedema in a large series of patients.
Franco Rongioletti +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinics in Dermatology, 2006
Scleromyxedema is a rare cutaneous mucinous disease characterized by a generalized papular sclerodermoid eruption and systemic manifestations that can lead to significant morbidity and mortality. Although its etiology remains unknown, most theories focus on a pathogenic role by paraproteins; it must be noted, however, that nonparaprotein factors have ...
Clara-Dina, Cokonis Georgakis +3 more
+6 more sources
Scleromyxedema is a rare cutaneous mucinous disease characterized by a generalized papular sclerodermoid eruption and systemic manifestations that can lead to significant morbidity and mortality. Although its etiology remains unknown, most theories focus on a pathogenic role by paraproteins; it must be noted, however, that nonparaprotein factors have ...
Clara-Dina, Cokonis Georgakis +3 more
+6 more sources
Pharmacotherapy of scleromyxedema
Expert Opinion on Orphan Drugs, 2013 Introduction: Scleromyxedema is a rare primary cutaneous mucinosis with a chronic and progressive course and possible severe systemic complications. There is no consensus on the optimal treatment for this potentially fatal disease because of the rarity ...
E Cinotti, Franco Rongioletti
exaly +2 more sources
Journal of the American Academy of Dermatology, 1999
Scleromyxedema is a sclerotic variant of papular mucinosis, in which lichenoid papules and scleroderma-like features are present. We describe a patient with scleromyxedema with IgG type lambda chain paraprotein, a systemic sclerosis-like illness, and myositis.
Z, Bata-Csorgo +6 more
openaire +2 more sources
Scleromyxedema is a sclerotic variant of papular mucinosis, in which lichenoid papules and scleroderma-like features are present. We describe a patient with scleromyxedema with IgG type lambda chain paraprotein, a systemic sclerosis-like illness, and myositis.
Z, Bata-Csorgo +6 more
openaire +2 more sources
Journal of the American Academy of Dermatology, 1995
Scleromyxedema is a rare fibromucinous disorder that is often difficult to treat and that is associated with significant morbidity and mortality.Our purpose was to study the natural history of the disease and its response to therapy with alkylating agents.A clinicopathologic review of 26 patients with scleromyxedema was performed, and the ...
A M, Dinneen, C H, Dicken
openaire +2 more sources
Scleromyxedema is a rare fibromucinous disorder that is often difficult to treat and that is associated with significant morbidity and mortality.Our purpose was to study the natural history of the disease and its response to therapy with alkylating agents.A clinicopathologic review of 26 patients with scleromyxedema was performed, and the ...
A M, Dinneen, C H, Dicken
openaire +2 more sources
Archives of Dermatology, 1976
An unusual, nodulocystic form of scleromyxedema (lichen myxedematosus) developed in a 48-year-old man with a six-year history of psoriasis. The scleromyxedema responded to intermittent therapy with melphalan and prednisone. Dermabrasion smoothed and softened the skin and increased the mobility of the perioral skin.
R C, Wright +3 more
openaire +3 more sources
An unusual, nodulocystic form of scleromyxedema (lichen myxedematosus) developed in a 48-year-old man with a six-year history of psoriasis. The scleromyxedema responded to intermittent therapy with melphalan and prednisone. Dermabrasion smoothed and softened the skin and increased the mobility of the perioral skin.
R C, Wright +3 more
openaire +3 more sources